Tuberculosis, also called “TB” (short for tubercle bacillus), is a common and often deadly infectious disease caused by mycobacteria.


According to Wikipedia, “Tuberculosis typically attacks the lungs, but can also affect other parts of the body. It is spread through the air when people who have an active TB infection cough, sneeze, or otherwise transmit respiratory fluids through the air.”

TB is the second-most common cause of death from infectious disease worldwide, with HIV/AIDS being first. According to researchers, there are up to 13.7 million active cases of TB worldwide at any given time, resulting in 1.3 to 1.5 million deaths annually.

TB infections are extremely difficult to cure. Standard treatment for TB consists of the daily use of at least four different antibiotics for up to18 to 24 months.

Worse yet, cases of multiple-drug-resistant TB are now running rampant in some countries. And the mortality rates are skyrocketing.

Is colloidal silver effective against Tuberculosis? Here’s what we know so far…

In this clinical study, entitled “Nature-inspired Novel Drug Design Paradigm Using Nanosilver: Efficacy on Multi-drug-resistant Clinical Isolates of Tuberculosis,” researchers found that when testing a “novel form” of metallic nanosilver against antibiotic-resistant tuberculosis (TB), the pathogens were killed rapidly and successfully.

The researchers state that by capping (i.e, coating) metallic silver nanoparticles with bovine serum albumin and then testing it in the laboratory against sputum samples collected from pulmonary TB patients with multi-drug-resistant TB, they were able to demonstrate that this “novel nanosilver compound” constitutes a “potent anti-TB drug.”

The “Novel Drug” Ruse

While the study results are extremely encouraging, the idea that you need to “cap” (i.e., coat) metallic silver nanoparticles with a chemical substance in order to make them “less toxic” to the human body is ludicrous and counterproductive, as I’ll explain below.

In reality, the researchers coated the metallic silver nanoparticles with bovine serum albumin because they were attempting to come up with a “novel invention” so they could obtain FDA “drug” status for it, patent it, and monopolize its sale globally.

They as much as admitted so in the conclusion to their study, where they state, “Encouragingly, the results indicate that this novel design could be further extended for developing improved medicinal agents for combating multi-drug-resistant TB.” (See Current Microbiology, 2011, 62:715-726.)

There is really no other “benefit” to coating the metallic silver nanoparticles with bovine serum albumin.

You see, when metallic silver nanoparticles are coated with any substance, whether it’s bovine serum albumin, or milk protein, or PVP, or any other, the effectiveness of the silver against pathogens is dramatically limited.

That’s because coating the silver nanoparticles greatly diminishes their ability to release silver ions inside the human body.

And silver ions are what actually kill the pathogens, not the metallic silver nanoparticle being ingested (see “Experts: It’s the Silver Ion that Gives Colloidal Silver It’s Antimicrobial Power.”)

So for the coated metallic silver nanoparticles to release enough silver ions to be effective against pathogens, a person would have to ingest two or three times more nanosilver than they would if the silver nanoparticles had not been coated.

And that means the liver and the kidneys will have to deal with two or three times more silver “load” on the body than they otherwise would have. This is most definitely not prudent or wise.

A far safer and more effective way to go would have been to leave the silver nanoparticles uncoated, but use one-third to one-half the dose.

That far lower load of nanosilver on the body would give the researchers all of the safety and low toxicity they claim to have been looking for in the first place. And it would allow more than enough silver ions to be released from the uncoated silver nanoparticles to do the job against the pathogens.

The bottom line is this: The whole idea that capping the silver particles makes them “less toxic” to humans is ridiculous, because you’re in essence forcing the infected individual to ingest two or three times more silver than necessary to kill the pathogens.

But using far smaller dosages of uncoated silver nanoparticles would allow the release of free silver ions (which kills the pathogens), while putting a mere one-third to one-half the silver load on the liver and kidneys.

What’s really happening here is that the medical researchers and the big drug companies want desperately to enter the market for silver-based infection-fighting substances.

After all, they know that silver is far more effective against infectious microorganism than their failing prescription antibiotic drugs.

Great News

In spite of my concerns about the use of coated silver nanoparticles in the above-described is study, the conclusions drawn by the study authors are nevertheless exciting and eye-opening, because it means silver has been clinically proven to destroy TB.

This once again confirms the incredible infection-fighting power of silver against infectious microbes – even drug-resistant microbes like the TB pathogen.

Think about it: Even silver nanoparticles coated with bovine serum albumin (which dramatically reduces their effectiveness) worked well against the drug-resistant TB pathogen in this study.


Can you imagine how well it might have worked if the silver nanoparticles were uncoated, or if pure ionic silver (i.e., colloidal silver) had been used instead of some “novel” new invention?

So why not just tell people that small doses of safe, natural colloidal silver – consisting largely of pure silver ions which are the active, infection-fighting form of silver – could just as effectively be used to kill the TB pathogen?

Look…millions of people worldwide have been ingesting tiny silver nanoparticles and pure silver ions in moderation for decades now, without undue harm or risk.

Another Interesting Study

Another interesting clinical study adds to the weight of evidence that silver just might be the once-and-for-all-times cure for tuberculosis.

Cells and Materials (Vol. 11). It demonstrated that silver nanoparticles at a concentration of only 10 ppm was effective against Mycobacterium tuberculosis.

The researchers stated:

“Silver nanoparticles were successfully produced less than 10nm in size.

They showed excellent antibacterial activities against S. typhi, E. coli, P. aeruginosa around 1 ppm and S. aureus and M. tuberculosis around 10 ppm.

Three types of antimicrobial mechanisms were observed:

1) Plasmolysis, cytoplasm of bacteria separated from bacterial cell wall, was observed in Gram negative bacteria

2) The synthesis of bacterial cell wall was inhibited in S. aureus.

3) Nanosilver particles found in the cytoplasm of M. tuberculosis may induce metabolic disturbance.”

The researchers concluded:

“Silver nanoparticles…showed excellent antibacterial activity. Antimicrobial mechanisms of nanosilver were different according to the species of bacteria. From the result, silver nanoparticles will be available as a good antibiotic alternative.”

So it appears from this study that the tiny silver nanoparticles “induced metabolic disturbance” in Mycobacterium tuberculosis, and killed them at 10 ppm, while killing Staphylococcus aureus, Pseudomona aeruginosa and Escherichia coli at only 1 ppm.

Can Colloidal Silver Cure TB?


Is colloidal silver effective against Tuberculosis? – google image 

While the two studies discussed above demonstrate that silver can indeed be used to kill the TB pathogen, they do not prove that silver is a “cure” for TB in the human body. More studies need to be done. But the current studies are cause for much hope.

There are also some citations in very old medical literature (circa 1900) for the use of colloidal silver as a remedy for tuberculosis.

But you have to keep in mind that most of the formulations of colloidal silver used back then were often chemical in nature, which is to say, they were not electrically generated colloidal silver, but instead silver compounds made through a chemical process.

According to American Biotech Labs, a company which has paid for private studies to be conducted on colloidal silver in different areas of the world, colloidal silver has been used in Ghana, West Africa, to successfully treat such diseases as tuberculosis, malaria, gonorrhea, and more.

You might also find it worthwhile to do a Google search for US Patent #7,135,195. This patent claims that colloidal silver is very effective against the tuberculosis pathogen.

The patent claim, of course, only applies to the specific brand of colloidal silver discussed in the patent. And treating any serious disease, including TB, should be done only under the supervision of a licensed medical practitioner.

But the patent is one more link in the chain of evidence suggesting that colloidal silver could be highly effective against the tuberculosis pathogen in the human body, just as it is against so many other pathogens.

According to the “Purpose” and “Conclusions” sections of the patent dealing with their study on colloidal silver and the tuberculosis bacteria (section 9, “Evidence of Efficacy of 10 ppm Silver Against Tuberculosis Bacteria”), colloidal silver at only 10 ppm has been demonstrated to effectively kill the TB bacteria:


…The use of silver compositions of the present invention is effective against tuberculosis bacteria.

A method comprising the step of administering silver compositions of the present invention is effective against tuberculosis organisms.”

So it’s fascinating that only 10 ppm colloidal silver was shown to be effective against the tuberculosis pathogen in the study cited in the above-mentioned patent.

However, it’s important to note that this claim is based on a test-tube study used in the patenting of a colloidal silver-based product. It was not a human study. So we still await further clinical studies before drawing any hard-and-fast conclusions.

But as biologist James South, MA, once wrote in the International Anti-Aging Bulletin:

“From 1900 to the beginning of the modern antibiotic era – circa 1940 with the introduction of sulfa drugs – Silver was one of the mainstays of medical practice in Europe and America.

Various forms of Silver were used to treat literally hundreds of ailments: lung infections such as pneumonia, tuberculosis and pleurisy; sexual diseases such as gonorrhea and syphillis; plus…

…skin conditions such as cuts, wounds, leg ulcers, pustular eczema, impetigo and boils; acute meningitis and epidemic cerebro-spinal meningitis; infectious diseases such as Mediterranean fever, erysipelas…

…cystitis, typhus, typhoid fever, and tonsilitis; eye disorders such as dacryocystitis, corneal ulcers, conjunctivitis and blepharitis; and various forms of septicemia, including puerperal fever, peritonitis and post-abortion septicemia.”

And as Dr. Kent Holtorf, M.D., of the Holtorf Medical Group has stated:

“Silver formulations have also been used in hundreds of various infections and other conditions including pneumonia, tuberculosis, eczema, meningitis, erysipelas, Mediterranean fever, corneal ulcers, conjunctivitis and septicemia.”

In 1910, Dr Henry Crooks a pioneer in colloidal chemistry wrote that:

“…certain metals such as silver, when in a colloidal state, have a highly germicidal action but are quite harmless to human beings

…Bronchial tuberculosis…Staphylococcus pyogenes, various Streptococci and other pathogenic organisms are all killed in three to four minutes:

in fact no microbe is known that is not killed by this colloid in laboratory experiments in six minutes, [and] the concentration of the [silver] does not exceed twenty-five parts per million…”

And as Alfred B. Searle wrote in 1921, his book, Use of Colloids in Health & Disease:

“…it is now definitely known that the germicidal properties of certain colloidal metals are based chiefly on the fact that the metals are in the colloidal state…

…a vigorous growth of b. tuberculosis was killed by colloidal silver in four minutes (a solution of 1 part silver to 2,000 parts fluid).”

Finally, the well-known and highly respected Dr. Gordon Pedersen wrote, in his 2014 book “A New Fighting Chance”:

“Tuberculosis is a common and often deadly infectious disease caused by mycobacteria.

…silver has destroyed tuberculosis in laboratory studies.

By drinking two teaspoons twice daily and inhaling from a nebulizer 30 minutes each day, you may affect the tuberculosis in both the lungs and the bloodstream.

Tuberculosis is not easy to beat. This dosage may need to be followed for weeks or months. You should see benefits after the first dose and each repeated use.”

So perhaps if clinical researchers were more interested in curing disease than in making money for their pharmaceutical company masters, we’d know by now whether or not colloidal silver effective against Tuberculosis, now that the dread disease is becoming endemic once again worldwide.


Leave a comment

Item added to cart.
0 items - VND0